Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
Cancer Science|October 20, 2012
Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patientsHidekazu Kameshima, Tetsuhiro Tsuruma, Goro Kutomi, et al.Nanomedicine (London, England)|October 17, 2012
T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticlesAkira Ito, Masaki Yamaguchi, Noriaki Okamoto, et al.Experimental and Molecular Pathology|October 16, 2012
DNA methyltransferase 1 is essential for initiation of the colon cancersRena Morita, Yoshihiko Hirohashi, Hiromu Suzuki, et al.Journal of Immunological Methods|November 26, 2002
Improved generation of HLA class I/peptide tetramersYuriko Sato, Hiroeki Sahara, Tomohide Tsukahara, et al.The American Journal of Pathology|March 26, 2011
Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cellsSatoko Inoda, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancerHiroyuki Hariu, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.The Journal of Investigative Dermatology|March 20, 2009
N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cellsMakito Sato, Toshiharu Yamashita, Masae Ohkura, et al.Journal of Skin Cancer|March 28, 2013
Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite NanoparticlesKowichi Jimbow, Yasue Ishii-Osai, Shosuke Ito, et al.Anticancer Research|December 26, 2012
Expression and function of FERMT genes in colon carcinoma cellsKenji Kiriyama, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.Cancer Science|May 23, 2009
Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4Munehide Nakatsugawa, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.Pageof 10